Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,748 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oxytocin Receptor Polymorphism Is Associated With Sleep Apnea Symptoms.
Goto H, Yamamoto Y, Tsujiguchi H, Sato T, Yamamoto R, Takeshita Y, Nakano Y, Kannon T, Hosomichi K, Suzuki K, Nakamura M, Kambayashi Y, Zhao J, Asai A, Katano K, Ogawa A, Fukushima S, Shibata A, Suzuki F, Tsuboi H, Hara A, Kometani M, Karashima S, Yoneda T, Tajima A, Nakamura H, Takamura T. Goto H, et al. J Endocr Soc. 2024 Nov 26;9(1):bvae198. doi: 10.1210/jendso/bvae198. eCollection 2024 Nov 26. J Endocr Soc. 2024. PMID: 39606181 Free PMC article.
Effects of eicosapentaenoic acid on serum levels of selenoprotein P and organ-specific insulin sensitivity in humans with dyslipidemia and type 2 diabetes.
Takeshita Y, Teramura C, Kamoshita K, Takayama H, Nakagawa H, Enyama Y, Ishii KA, Tanaka T, Goto H, Nakano Y, Osada S, Tanaka Y, Tokuyama K, Takamura T. Takeshita Y, et al. Among authors: goto h. J Diabetes Investig. 2022 Mar;13(3):532-542. doi: 10.1111/jdi.13699. Epub 2021 Nov 9. J Diabetes Investig. 2022. PMID: 34670012 Free PMC article. Clinical Trial.
Insulin-glucagon-like peptide-1 receptor agonist relay and glucagon-like peptide-1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open-label trial study.
Takeshita Y, Kita Y, Tanaka T, Goto H, Nakano Y, Teramura C, Enyama Y, Takamura T; Establishment of Rationale for Antiaging Diabetic Medicine (ERA-DM) Study Group. Takeshita Y, et al. Among authors: goto h. J Diabetes Investig. 2022 Jun;13(6):965-974. doi: 10.1111/jdi.13749. Epub 2022 Feb 8. J Diabetes Investig. 2022. PMID: 35034428 Free PMC article. Clinical Trial.
Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial.
Takeshita Y, Honda M, Harada K, Kita Y, Takata N, Tsujiguchi H, Tanaka T, Goto H, Nakano Y, Iida N, Arai K, Yamashita T, Mizukoshi E, Nakamura H, Kaneko S, Takamura T. Takeshita Y, et al. Among authors: goto h. Diabetes Care. 2022 Sep 1;45(9):2064-2075. doi: 10.2337/dc21-2049. Diabetes Care. 2022. PMID: 35894933 Free PMC article. Clinical Trial.
Selenoprotein P deficiency protects against immobilization-induced muscle atrophy by suppressing atrophy-related E3 ubiquitin ligases.
Abuduwaili H, Kamoshita K, Ishii KA, Takahashi K, Abuduyimiti T, Qifang L, Isobe Y, Goto H, Nakano Y, Takeshita Y, Takayama H, Harada K, Takamura T. Abuduwaili H, et al. Among authors: goto h. Am J Physiol Endocrinol Metab. 2023 Jun 1;324(6):E542-E552. doi: 10.1152/ajpendo.00270.2022. Epub 2023 Mar 22. Am J Physiol Endocrinol Metab. 2023. PMID: 36947851 Free article.
PAC1 Deficiency Protects Obese Male Mice From Immobilization-Induced Muscle Atrophy by Suppressing FoxO-Atrogene Axis.
Li Q, Ishii KA, Kamoshita K, Takahashi K, Abuduwaili H, Takayama H, Galicia-Medina CM, Tanida R, Ko Oo H, Gafiyatullina G, Yao X, Abuduyimiti T, Hamazaki J, Goto H, Nakano Y, Takeshita Y, Harada K, Murata S, Takamura T. Li Q, et al. Among authors: goto h. Endocrinology. 2023 Apr 17;164(6):bqad065. doi: 10.1210/endocr/bqad065. Endocrinology. 2023. PMID: 37103220 Free PMC article.
Nutrigenetic Interaction Between Apolipoprotein C3 Polymorphism and Fat Intake in People with Nonalcoholic Fatty Liver Disease.
Yamamoto R, Takeshita Y, Tsujiguchi H, Kannon T, Sato T, Hosomichi K, Suzuki K, Kita Y, Tanaka T, Goto H, Nakano Y, Yamashita T, Kaneko S, Tajima A, Nakamura H, Takamura T. Yamamoto R, et al. Among authors: goto h. Curr Dev Nutr. 2023 Mar 2;7(4):100051. doi: 10.1016/j.cdnut.2023.100051. eCollection 2023 Apr. Curr Dev Nutr. 2023. PMID: 37304843 Free PMC article.
3,748 results